From rats to humans and return: Testing addiction hypotheses by combined PET imaging and self-reported measures of psychostimulant effects. Commentary on Volkow et al. 'Role of dopamine in drug reinforcement and addiction in humans: Results from imaging studies'

Behavioural Pharmacology

Volumn 13, Issue 5-6, 2002, Pages 371-377

  Di Chiara, G ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON 11; COCAINE; DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR BLOCKING AGENT; DOPAMINE TRANSPORTER; METHYLPHENIDATE; PSYCHOSTIMULANT AGENT;

ADDICTION; ANIMAL MODEL; COCAINE DEPENDENCE; DOPAMINERGIC SYSTEM; DOPAMINERGIC TRANSMISSION; DRUG ABUSE; HUMAN; IMAGING SYSTEM; NEURORADIOLOGY; NONHUMAN; NOTE; POSITRON EMISSION TOMOGRAPHY; RAT; REINFORCEMENT; SELF REPORT;

EID: 0036749562     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008877-200209000-00010     Document Type: Note

References (33)

1. Bergman J, Madras BK, Johnson SE, Spealman RD (1989). Effects of cocaine and related drugs in nonhuman primates. III. Self-administration by squirrel monkeys. J Pharmacol Exp Ther 251:150-155.
2. Berridge KC, Robinson TE (1998). What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience? Brain Res Brain Res Rev 28:309-369.
3. Bradberry CW (2000). Acute and chronic dopamine dynamics in a nonhuman primate model of recreational cocaine use. J Neurosci 20:7109-7115.
4. Brauer LH, Goudie AJ, de Wit H (1997). Dopamine ligands and the stimulus effects of amphetamine: animal models versus human laboratory data. Psychopharmacology (Berl) 130:2-13.
5. Brady JV, Griffiths RR (1976). Behavioral procedures for evaluating the relative abuse potential of CNS drugs in primates. Fed Proc.35:2245-2253h.
6. Cadoni C, Solinas M, Di Chiara G (2000). Psychostimulant sensitization: differential changes in accumbal shell and core dopamine. Eur J Pharmacol 388:69-76.
7. Di Chiara G (1998). A motivational learning hypothesis of the role of dopamine in compulsive drug use. J Psychopharmacol 12:54-67.
8. Di Chiara G. (2002). Dopamine and reward. In Handbook of Experimental Pharmacology 154 'Dopamine in the CNS', vol. II (Di Chiara G, ed), Springer, Heidelberg pp. 265-319.
9. Drevets WC, Gautier C, Price JC, Kupfer DJ, Kinahan PE, Grace AA, Price JL, Mathis CA (2001). Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria. Biol Psychiatry 49:81-96.
10. Hooks MS, Duffy P, Striplin C, Kalivas PW (1994). Behavioral and neurochemical sensitization following cocaine self-administration. Psychopharmacology (Berl) 115:265-272.
11. Johanson CE, Schuster CR (1975). A choice procedure for drug reinforcers: cocaine and methylphenidate in the rhesus monkey. J Pharmacol Exp Ther 193:676-688.
12. Kalivas PW, Duffy P (1993). Time course of extracellular dopamine and behavioral sensitization to cocaine. I. Dopamine axon terminals. J Neurosci 13:266-275.
13. Maisonneuve IM, Kreek MJ (1994). Acute tolerance to the dopamine response induced by a binge pattern of cocaine administration in male rats: an in vivo microdialysis study. J Pharmacol Exp Ther 268:916-921.
14. Maisonneuve IM, Ho A, Kreek MJ (1995). Chronic administration of a cocaine "binge" alters basal extracellular levels in male rats: an in vivo microdialysis study. J Pharmacol Exp Ther 272:652-657.
15. Robinson TE, Berridge KC (1993). The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res. Rev ; 18:247-291.
16. Romach MK, Glue P, Kampman K, Kaplan HL, Somer GR, Poole S, Clarke L, Coffin V, Cornish J, O'Brien CP, Sellers EM (1999). Attenuation of the euphoric effects of cocaine by the dopamine D1/D5 antagonist ecopipam (SCH 39166). Arch Gen Psychiatry 56:1101-1106.
17. Sax KW, Strakowski SM (2001). Behavioral sensitization in humans. J Addict Dis 20:55-65.
18. Segal DS, Kuczenski R (1992). Repeated cocaine administration induces behavioral sensitization and corresponding decreased extracellular dopamine responses in caudate and accumbens. Brain Res 577:351-355.
19. Tsukada H, Kreuter J, Maggos CE, Unterwald EM, Kakiuchi T, Nishiyama S, Futatsubashi M, Kreek MJ (1996). Effects of binge pattern cocaine administration on dopamine D1 and D2 receptors in the rat brain: an in vivo study using positron emission tomography. J Neurosci 16:7670-7677.
20. Unterwald EM, Ho A, Rubenfeld JM, Kreek MJ (1994). Time course of the development of behavioral sensitization and dopamine receptor up-regulation during binge cocaine administration. J Pharmacol Exp Ther 270:1387-1396.
21. Volkow ND, Fowler JS, Wang GJ, Hitzemann R, Logan J, Schlyer DJ, Dewey SL, Wolf AP (1993). Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers. Synapse 14:169-177.
22. 11C]raclopride in the human brain. Synapse 16:255-262.
23. Volkow ND, Ding U, Fowler JS, Wang GJ, Logan J, Gatley JS, Dewey SL, Ashby C, Lieberman J, Hitzemann R, Wolf AP (1995). Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in human brain. Arch Gen Psychiatry 52:456-463.
24. Volkow ND, Fowler JS (2000). Addiction, a disease of compulsion and drive: involvement of the orbitofrontal cortex. Cereb Cortex 10:318-325.
25. Volkow ND, Wang G-J, Fischman MW, Foltin RW, Fowler JS, Vitkun S, Logan J, Gatley SJ, Pappas N, Hitzemann R, Shea K (1997a). Relationship between subjective effects of cocaine and dopamine transporter occupancy. Nature 386:827-830.
26. Volkow ND, Wang G-J, Fowler JS, Logan J, Gatley SJ, Hitzemann R, Chen AD, Pappas N (1997b). Decreased striatal dopaminergic responsivity in detoxified cocaine abusers. Nature 386:830-833.
27. Volkow ND, Wang G-J, Fowler JS, Gatley SJ, Logan J, Ding Y-S, Dewey SL, Hitzemann R, Gifford A, Pappas NR (1999a). Blockade of striatal dopamine transporters by intravenous methylphenidate is not sufficient to induce self-reports of "High". J Pharmacol Exp Ther 288:14-20.
28. Volkow ND, Wang GJ, Fowler JS, Fischman M, Foltin R, Gatley SJ, Logan J, Wong C, Gifford A, Hitzemann R, Pappas N (1999b). Methylphenidate and cocaine have a similar in vivo potency to block dopamine transporters in the human brain. Life Sci 65:7-12.
29. Volkow ND, Wang G-J, Fowler JS, Logan J, Gatley SJ, Wong C, Hitzemann RJ, Pappas N (1999c). Reinforcing effects of psychostimulants in humans are associated with increases in brain dopamine and occupancy of D2 receptors. J Pharmacol Exp Ther 291:409-415.
30. Volkow ND, Wang G-J, Fowler JS, Logan J, Gatley SJ, Gifford A, Hitzemann R, Ding Y-S, Pappas N (1999d). Prediction of reinforcing responses to psychostimulants in humans by brain dopamine D2 receptor levels. Am J Psychiatry 156:1440-1443.
31. Volkow ND, Wang GJ, Fischman M, Foltin R, Fowler JS, Franceschi D, Franceschi M, Logan J, Gatley SJ, Wong C, Ding Y-S, Hitzemann R, Pappas N (2000). Effects of route of administration on cocaine induced dopamine transporter blockade in the human brain. Life Sciences 67:1507-1515.
32. Volkow N, Fowler SJ, Wang GJ (2002). Role of dopamine in drug reinforcement and addiction in humans: results from imaging studies. Behav Pharmacol 13:355-366.
33. Weiss F, Markou A, Lorang MT, Koob GF (1992). Basal extracellular dopamine levels in the nucleus accumbens are decreased during cocaine withdrawal after unlimited-access self-administration. Brain Res 593:314-318.